| 113.05 Delayed Data As of Nov 15 |  +3.18 / +2.89%Today’s Change | 64.72 Today|||52-Week Range 113.12 | +58.31% Year-to-Date |
| Neurocrine Biosciences Inc (NBIX) Q3 2019 Earnings Call Transcript Nov 04 / MotleyFool.com - Paid Partner Content |
| Previous close | 109.87 |
| Today’s open | 109.58 |
| Day’s range | 109.50 - 113.12 |
| Volume | 660,600 |
| Average volume (3 months) | 699,339 |
| Market cap | $10.4B |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +238.52% |
| Earnings growth (next 5 years) | +78.00% |
| Revenue growth (last year) | +179.19% |
| P/E ratio | 513.9 |
| Price/Sales | 15.10 |
| Price/Book | 21.35 |
| Today’s change | Today’s % change | |
|---|---|---|
| EXASExact Sciences Corp | +2.81 | +3.55% |
| TECHBio-Techne Corp | +8.87 | +4.36% |
| BMRNBiomarin Pharmaceuti... | -0.54 | -0.71% |
| MRNAModerna Inc | +1.03 | +5.62% |
| Next reporting date | February 6, 2020 |
| EPS forecast (this quarter) | $0.70 |
| Annual revenue (last year) | $451.2M |
| Annual profit (last year) | $21.1M |
| Net profit margin | 4.68% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Diego, California |
